BC
RVMD icon

Bridgefront Capital’s Revolution Medicines RVMD Stock Holding History

Bridgefront Capital’s Portfolio RVMD Stock Details RVMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-7,515
Closed -$731K – 710
2026
Q1 		$731K Sell
7,515
-8,041
-52% -$812K 0.18% 188
2025
Q4 		$1.24M Buy
+15,556
New +$1.02M 0.31% 92
2025
Q3 		– Sell
-6,542
Closed -$241K – 797
2025
Q2 		$241K Buy
+6,542
New +$251K 0.06% 499
2021
Q3 		– Sell
-7,733
Closed -$245K – 618
2021
Q2 		$245K Buy
+7,733
New +$270K 0.09% 427

Other funds holding RVMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.76B AUM 342.13% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return

Bridgefront Capital's RVMD Position: Q2 2026 in Review

Bridgefront Capital sold out of Revolution Medicines (RVMD) in Q2 2026, closing a stake of 7,515 shares — an estimated $731K sold.

Bridgefront Capital first reported a position in RVMD in Q2 2021 and held it in 4 quarters. The position peaked at $1.24M in Q4 2025. 694 funds tracked by Wall St. Rank hold RVMD as of Q2 2026.

  • Bridgefront Capital reported no remaining Revolution Medicines position as of Q2 2026 after selling out during the quarter.
  • Bridgefront Capital sold 7,515 Revolution Medicines shares in Q2 2026, an estimated $731K.
  • Bridgefront Capital first reported a position in Revolution Medicines in Q2 2021 and held it in 4 quarters.
  • Bridgefront Capital's Revolution Medicines position peaked at $1.24M in Q4 2025.
  • 694 funds tracked by Wall St. Rank held Revolution Medicines as of Q2 2026.

Based on Bridgefront Capital's 13F filing for Q2 2026, filed 14 Aug 2026.